Literature DB >> 17207829

Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: acute phase replication and reactivation in mice.

John W Balliet1, Anna S Kushnir, Priscilla A Schaffer.   

Abstract

A recombinant HSV-1 virus expressing EGFP from the HCMV major immediate early promoter (KOS-CMVGFP) was constructed to monitor viral replication and spread in vitro and in mice. KOS-CMVGFP replicated as efficiently as wild-type virus, strain KOS, in single cycle growth experiments in Vero cells indicating that the recombinant virus has no significant growth defects in vitro. Following ocular inoculation of mice, KOS-CMVGFP exhibited slight but statistically significant reductions in mouse tear film titers relative to wild-type virus. Progression of virus infection of the eyes, periocular tissue, and snout was readily followed by fluorescence microscopy. Insertion of the EGFP expression cassette into the KOS genome had no effect on the efficiency of establishment of latency as determined by quantitative competitive PCR of viral genomes in latently infected TG. KOS-CMVGFP reactivated with wild-type kinetics and efficiency by explant cocultivation, but exhibited a significant delay in the kinetics and a modest reduction in the efficiency of reactivation compared to KOS in the more sensitive TG cell culture model. Notably, EGFP expression preceded the detection of infectious virus by greater than 24 h in both ex vivo models and thus is a useful marker of the early stages in the induction of reactivation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17207829      PMCID: PMC1975764          DOI: 10.1016/j.virol.2006.11.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  40 in total

1.  Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system.

Authors:  J A Palmer; R H Branston; C E Lilley; M J Robinson; F Groutsi; J Smith; D S Latchman; R S Coffin
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Immunohistochemical analysis of primary sensory neurons latently infected with herpes simplex virus type 1.

Authors:  L Yang; C C Voytek; T P Margolis
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice.

Authors:  Gary D Luker; J Patrick Bardill; Julie L Prior; Christina M Pica; David Piwnica-Worms; David A Leib
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency.

Authors:  W P Halford; P A Schaffer
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo.

Authors:  W P Halford; P A Schaffer
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Point mutations in herpes simplex virus type 1 oriL, but not in oriS, reduce pathogenesis during acute infection of mice and impair reactivation from latency.

Authors:  John W Balliet; Priscilla A Schaffer
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Herpes simplex virus type 1 corneal infection results in periocular disease by zosteriform spread.

Authors:  B C Summers; T P Margolis; D A Leib
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

8.  Tracking the spread of a lacZ-tagged herpes simplex virus type 1 between the eye and the nervous system of the mouse: comparison of primary and recurrent infection.

Authors:  C Shimeld; S Efstathiou; T Hill
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

9.  Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice.

Authors:  Lawrence T Feldman; Aaron R Ellison; Cynthia C Voytek; Li Yang; Philip Krause; Todd P Margolis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

10.  Re-evaluating natural resistance to herpes simplex virus type 1.

Authors:  William P Halford; John W Balliet; Bryan M Gebhardt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more
  16 in total

1.  Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice.

Authors:  Derek J Royer; Meghan M Carr; Ana J Chucair-Elliott; William P Halford; Daniel J J Carr
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

2.  Systematic assembly of a full-length infectious clone of human coronavirus NL63.

Authors:  Eric F Donaldson; Boyd Yount; Amy C Sims; Susan Burkett; Raymond J Pickles; Ralph S Baric
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

3.  ICP0 dismantles microtubule networks in herpes simplex virus-infected cells.

Authors:  Mingyu Liu; Edward E Schmidt; William P Halford
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

4.  Structure of the herpes simplex virus 1 genome: manipulation of nicks and gaps can abrogate infectivity and alter the cellular DNA damage response.

Authors:  Samantha Smith; Nina Reuven; Kareem N Mohni; April J Schumacher; Sandra K Weller
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

5.  Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters.

Authors:  Srividya Ramachandran; Jared E Knickelbein; Christina Ferko; Robert L Hendricks; Paul R Kinchington
Journal:  Virology       Date:  2008-07-11       Impact factor: 3.616

6.  ICP0 antagonizes ICP4-dependent silencing of the herpes simplex virus ICP0 gene.

Authors:  Mingyu Liu; Brandon Rakowski; Edward Gershburg; Carla M Weisend; Olivier Lucas; Edward E Schmidt; William P Halford
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

7.  A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones.

Authors:  João T Proença; Heather M Coleman; Viv Connor; Douglas J Winton; Stacey Efstathiou
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

8.  Entry of herpes simplex virus type 1 (HSV-1) into the distal axons of trigeminal neurons favors the onset of nonproductive, silent infection.

Authors:  Wali Hafezi; Eva U Lorentzen; Bodo R Eing; Marcus Müller; Nicholas J C King; Barbara Klupp; Thomas C Mettenleiter; Joachim E Kühn
Journal:  PLoS Pathog       Date:  2012-05-10       Impact factor: 6.823

9.  HSV-1 infection suppresses TGF-beta1 and SMAD3 expression in human corneal epithelial cells.

Authors:  Yuhong Nie; Dongmei Cui; Zhujuan Pan; Jiangyun Deng; Qiang Huang; Kaili Wu
Journal:  Mol Vis       Date:  2008-09-03       Impact factor: 2.367

Review 10.  Fluorescent Protein Approaches in Alpha Herpesvirus Research.

Authors:  Ian B Hogue; Jens B Bosse; Esteban A Engel; Julian Scherer; Jiun-Ruey Hu; Tony Del Rio; Lynn W Enquist
Journal:  Viruses       Date:  2015-11-19       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.